Vectron Biosolutions AS is your expert on developing cost-effective microbial production processes for recombinant proteins

Do you need to cut manufacturing costs?

The manufacturing costs of many recombinant proteins can be significantly reduced through increasing titres and improving the solubility of the proteins, reducing the necessities of costly downstream processes. This is increasingly important in the competitive landscape of the biopharmaceutical industry, especially with the advent of biosimilars and biobetters, as well as for suppliers of industrial enzymes where the markets are smaller.

Vectron Biosolutions is your upstream expert on developing robust, cost-efficient production processes for recombinant proteins in E. coli and other bacteria. We have proprietary next-generation expression tools and decades of experience that is available to you through partnerships and licensing.

Latest news

  • Vectron enters collaboration with Mycenax Biotech Inc.

    May 29 | 2019

    Vectron and Mycenax will collaborate to offer a complete and superior solution for microbial production of therapeutic proteins.

    Read more
  • Vectron Biosolutions participated on this year's VIVO career day at NTNU

    February 06 | 2019

    Read more
  • Vectron receives Fab grant from NFR

    February 04 | 2019

    A research grant for continued work on cost-efficient production of Fab therapeutic proteins has been received from NFR.

    Read more
  • Vectron signs license agreement with ArcticZymes

    December 20 | 2018

    Read more Download as PDF
Complete newslist

Events

Meet us there!
More events